Aurisco Pharmaceutical Co Ltd Net Asset Quality Index
Aurisco Pharmaceutical Co Ltd net asset quality index. Aurisco Pharmaceutical Co Ltd (605116) has a Net Asset Quality Index of 62.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.90 Billion minus total liabilities of CN¥1.47 Billion yields net assets of CN¥2.43 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Aurisco Pharmaceutical Co Ltd (605116) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Aurisco Pharmaceutical Co Ltd (2016–2024)
Net asset quality index of Aurisco Pharmaceutical Co Ltd from 2016 to 2024. This chart shows how Aurisco Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 62.2%, representing net assets of CN¥2.43 Billion against total assets of CN¥3.90 Billion CNY. Check Aurisco Pharmaceutical Co Ltd (605116) tangible net worth to evaluate the tangible quality of the company's equity base.
Aurisco Pharmaceutical Co Ltd Net Asset Quality Index by Year (2016–2024)
Aurisco Pharmaceutical Co Ltd net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Aurisco Pharmaceutical Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Aurisco Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 60.1% | CN¥2.33 Billion | CN¥3.88 Billion | CN¥1.55 Billion | ▼ -16.3 pp |
| 2023 | 76.4% | CN¥1.97 Billion | CN¥2.57 Billion | CN¥607.03 Million | ▼ -6.4 pp |
| 2022 | 82.8% | CN¥1.68 Billion | CN¥2.03 Billion | CN¥348.68 Million | ▼ -4.8 pp |
| 2021 | 87.6% | CN¥1.51 Billion | CN¥1.72 Billion | CN¥213.44 Million | ▼ -2.7 pp |
| 2020 | 90.3% | CN¥1.39 Billion | CN¥1.53 Billion | CN¥147.98 Million | ▲ +1.5 pp |
| 2019 | 88.8% | CN¥977.28 Million | CN¥1.10 Billion | CN¥122.96 Million | ▲ +3.3 pp |
| 2018 | 85.5% | CN¥787.54 Million | CN¥920.70 Million | CN¥133.16 Million | ▲ +1.8 pp |
| 2017 | 83.8% | CN¥683.95 Million | CN¥816.38 Million | CN¥132.44 Million | ▲ +8.3 pp |
| 2016 | 75.4% | CN¥589.81 Million | CN¥781.82 Million | CN¥192.01 Million | — |